Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
By H. Sung, J. Ferlay, R. Siegel, M. Laversanne, Isabelle Soerjomataram, A. Jemal, F. Bray. Ca, 2021
96,839 citations recorded by the source corpus.
This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer. Worldwide, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020. Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases (11.7%), followed by lung (11.4%), colorectal (10.0 %), prostate (7.3%), and stomach (5.6%) cancers. Lung cancer remained the leading cause of cancer death, with an estimated 1.8 million deaths (18%), followed by colorectal (9.4%), liver (8.3%), stomach (7.7%), and female breast (6.9%) cancers. Overall incidence was from 2‐fold to 3‐fold higher in transitioned versus transitioning countries for both sexes, whereas mortality varied <2‐fold for men and little for women. Death rates for female breast and cervical cancers, however, were considerably higher in transitioning versus transitioned countries (15.0 vs 12.8 per 100,000 and 12.4 vs 5.2 per 100,000, respectively). The global cancer burden is expected to be 28.4 million cases in 2040, a 47% rise from 2020, with a larger increase in transitioning (64% to 95%) versus transitioned (32% to 56%) countries due to demographic changes, although this may be further exacerbated by increasing risk factors associated with globalization and a growing economy. Efforts to build a sustainable infrastructure for the dissemination of cancer prevention measures and provision of cancer care in transitioning countries is critical for global cancer control.
Subfields: Epidemiology, Oncology
View Paper: https://www.semanticscholar.org/paper/474f691172792ba6b47c8a3010b7b6db8a4c9a48
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Oncology
Citations in the corpus
- Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies (2022, background): “In 2020, CRC was the most diagnosed cancer (out of 36 cancers) among men in 18 of the 186 countries worldwide and women in 6 of the 185 countries [24].”
- High resolution mapping of the tumor microenvironment using integrated single-cell, spatial and in situ analysis (2023, neutral): “Female breast cancer is the most commonly diagnosed cancer globally, with ~2.3 million new cases reported in 2020 25 , and the prevalence of cancer as a leading cause of premature death is ever-increasing worldwide, particularly in developing nations 26 .”
- Current and future burden of breast cancer: Global statistics for 2020 and 2040 (2022, background): “3 million new cases in both sexes combined [1].”
- Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma. (2022, neutral): “Constipation 59 (19) 2 (1) 7 (2) 1 (<1) 66 (22) 1 (<1)”
- Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050 (2023, background): “10 Knowing the economic cost of cancers enables policy makers to (1) enact appropriate policies to curb the increase in cancerrelated mortality and morbidity, (2) allocate resources appropriately, and (3) build health care systems that can cope effectively with expected increases in cancer prevalenc”
- Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 (2021, neutral): “mission, (3) metastatic/disseminated, and (4) terminal (eTable 11”
- Epidemiology of Melanoma (2021, background): “The incidence of melanoma has increased in developed, predominantly fair-skinned countries over the past decades [4].”
- Large-scale pancreatic cancer detection via non-contrast CT and deep learning (2023, neutral): “Pancreatic ductal adenocarcinoma (PDAC) is the deadliest solid malignancy worldwide, and causes approximately 466,000 deaths per year 1 .”
- Cancer statistics in China and United States, 2022: profiles, trends, and determinants (2022, background): “We included non-melanomas of the skin in total cancer cases and deaths [Table 1], but the ACS did not.([2,5,8,17])”